logo
Select company
Select metric
$ -1.73EBITDA per Share
VS
Market
13
Sector
35
Industry
46
History
85
$ 4.03Close
$ 1.96 - $ 4.21 52-Week Range
Ticker Information

Ticker

VTGN

Company Name

VISTAGEN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VISTAGEN THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VTGN - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -55.12M$ -1.73131.93M
3/31/2025$ -50.78M$ -1.64130.88M
12/31/2024$ -46.68M$ -1.52130.71M
9/30/2024$ -38.96M$ -1.27130.63M
6/30/2024$ -32.61M$ -1.07130.6M
3/31/2024$ -28.79M$ -1.49119.35M
12/31/2023$ -31.51M$ -1.07129.39M
9/30/2023$ -34.93M$ -4.0118.72M
6/30/2023$ -45.83M$ -6.2117.38M
3/31/2023$ -58.71M$ -8.4416.96M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VISTAGEN THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -6.95.
  • Over the past 5 years, VISTAGEN THERAPEUTICS INC's average EBITDAPS has been $ -4.44.
  • The median EBITDAPS for VISTAGEN THERAPEUTICS INC during this period was $ -3.75
  • VISTAGEN THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ -1.07.
  • The lowest EBITDAPS recorded by VISTAGEN THERAPEUTICS INC in the same timeframe $ -9.25

VISTAGEN THERAPEUTICS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
RNXT : RENOVORX INC $ -0.3BTAI : BIOXCEL THERAPEUTICS INC $ -4.41ABVC : ABVC BIOPHARMA INC $ -0.14COYA : COYA THERAPEUTICS INC $ -1.26AVTX : AVALO THERAPEUTICS INC $ -4.42ZTEK : ZENTEK LTD $ -0.06ENTX : ENTERA BIO LTD $ -0.23INO : INOVIO PHARMACEUTICALS INC $ -2.18RPTX : REPARE THERAPEUTICS INC $ -2.4LEXX : LEXARIA BIOSCIENCE CORP $ -0.62

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for VISTAGEN THERAPEUTICS INC is calculated as follows: EBITDA [ $ -15.54M ] / (Shares WA [ 2.24M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -6.95 ]

VTGN - EBITDA per Share, Last 5 years

$ -9.25

Minimum

Sep 30, 2022

$ -1.07

Maximum

Jun 30, 2024

$ -4.44

Average

$ -3.75

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -11.29
max$ 14.03
average$ 2.03
median$ 1
std$ 4.28